Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart disease and stroke statistics-2023 update: a report from the american heart association. Circulation. 2023;147:e93–e621. https://doi.org/10.1161/cir.0000000000001123

Article  PubMed  PubMed Central  Google Scholar 

Wu DF, Yin RX, Deng JL. Homocysteine, hyperhomocysteinemia, and H-type hypertension. Eur J Prev Cardiol. 2024;31:1092–103. https://doi.org/10.1093/eurjpc/zwae022

Article  PubMed  Google Scholar 

Hermann A, Sitdikova G Homocysteine: biochemistry, molecular biology and role in disease.Biomolecules. 2021;11. https://doi.org/10.3390/biom11050737

Liang Z, Fan FF, Zhang Y, Qin XH, Li JP, Huo Y. [Rate and characteristics of H-type hypertension in Chinese hypertensive population and comparison with American population]. Beijing Da Xue Xue Bao. 2022;54:1028–37. https://doi.org/10.19723/j.issn.1671-167X.2022.05.033

Article  CAS  PubMed  Google Scholar 

Qin X, Huo Y. H-Type hypertension, stroke and diabetes in China: Opportunities for primary prevention. J Diabetes. 2016;8:38–40. https://doi.org/10.1111/1753-0407.12333

Article  PubMed  Google Scholar 

Dong L, Liu J, Qin Y, Yang WJ, Nie L, Liu HN, et al. Relationship between ambulatory arterial stiffness index and the severity of angiographic atherosclerosis in patients with H-type hypertension and coronary artery disease. Clin Exp Hypertension (New York, NY: 1993). 2023;45:2228517 https://doi.org/10.1080/10641963.2023.2228517

Article  Google Scholar 

Lee-Rueckert M, Escola-Gil JC, Kovanen PT. HDL functionality in reverse cholesterol transport–Challenges in translating data emerging from mouse models to human disease. Biochim Biophys Acta. 2016;1861:566–83. https://doi.org/10.1016/j.bbalip.2016.03.004

Article  CAS  PubMed  Google Scholar 

Cochran BJ, Ong KL, Manandhar B, Rye KA. APOA1: a protein with multiple therapeutic functions. Curr Atheroscler Rep. 2021;23:11 https://doi.org/10.1007/s11883-021-00906-7

Article  CAS  PubMed  Google Scholar 

Kluck GEG, Qian AS, Sakarya EH, Quach H, Deng YD, Trigatti BL. Apolipoprotein A1 protects against necrotic core development in atherosclerotic plaques: PDZK1-dependent high-density lipoprotein suppression of necroptosis in macrophages. Arterioscler Thromb Vasc Biol. 2023;43:45–63. https://doi.org/10.1161/atvbaha.122.318062

Article  CAS  PubMed  Google Scholar 

Montecucco F, Favari E, Norata GD, Ronda N, Nofer JR, Vuilleumier N. Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions. Handb Exp Pharmacol. 2015;224:455–82. https://doi.org/10.1007/978-3-319-09665-0_14

Article  CAS  PubMed  Google Scholar 

Bhale AS, Venkataraman K. Leveraging knowledge of HDLs major protein ApoA1: Structure, function, mutations, and potential therapeutics. Biomed Pharmacother = Biomedecine & Pharmacotherapie. 2022;154:113634 https://doi.org/10.1016/j.biopha.2022.113634

Article  CAS  Google Scholar 

Florvall G, Basu S, Larsson A. Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men. J Gerontol A Biol Sci Med Sci. 2006;61:1262–6. https://doi.org/10.1093/gerona/61.12.1262

Article  PubMed  Google Scholar 

Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720–826. https://doi.org/10.1093/eurheartj/ehad191

Article  CAS  PubMed  Google Scholar 

Li J, Jiang S, Zhang Y, Tang G, Wang Y, Mao G, et al. H-type hypertension and risk of stroke in chinese adults: a prospective, nested case-control study. J Transl Int Med. 2015;3:171–8. https://doi.org/10.1515/jtim-2015-0027

Article  PubMed  PubMed Central  Google Scholar 

Lee TH, Hsu WC, Chen CJ, Chen ST. Etiologic study of young ischemic stroke in Taiwan. Stroke. 2002;33:1950–5. https://doi.org/10.1161/01.str.0000021409.16314.16

Article  PubMed  Google Scholar 

American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care. 2024;47:S20–s42. https://doi.org/10.2337/dc24-S002

Article  Google Scholar 

Rabar S, Harker M, O’Flynn N, Wierzbicki AS. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ (Clinical Research ed). 2014;349:g4356 https://doi.org/10.1136/bmj.g4356

Article  CAS  PubMed  Google Scholar 

Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016;152:1243–75. https://doi.org/10.1016/j.jtcvs.2016.07.044

Article  PubMed  Google Scholar 

Ott C, Schmieder RE. Diagnosis and treatment of arterial hypertension 2021. Kidney Int. 2022;101:36–46. https://doi.org/10.1016/j.kint.2021.09.026

Article  PubMed  Google Scholar 

Guieu R, Ruf J, Mottola G. Hyperhomocysteinemia and cardiovascular diseases. Ann Biol Clin (Paris). 2022;80:7–14. https://doi.org/10.1684/abc.2021.1694

Article  CAS  PubMed  Google Scholar 

Zhao W, Gao F, Lv L, Chen X. The interaction of hypertension and homocysteine increases the risk of mortality among middle-aged and older population in the United States. J Hypertens. 2022;40:254–63. https://doi.org/10.1097/hjh.0000000000003002

Article  CAS  PubMed  Google Scholar 

Stefanadis C, Antoniou CK, Tsiachris D, Pietri P. Coronary atherosclerotic vulnerable plaque: current perspectives. J Am Heart Assoc. 2017;6:e005543 https://doi.org/10.1161/jaha.117.005543

Article  CAS  PubMed  PubMed Central  Google Scholar 

He Y, Pavanello C, Hutchins PM, Tang C, Pourmousa M, Vaisar T, et al. Flipped C-Terminal ends of APOA1 promote ABCA1-dependent cholesterol efflux by small HDLs. Circulation. 2024;149:774–87. https://doi.org/10.1161/circulationaha.123.065959

Article  CAS  PubMed  Google Scholar 

Busnelli M, Manzini S, Chiara M, Colombo A, Fontana F, Oleari R, et al. Aortic gene expression profiles show how ApoA-I levels modulate inflammation, lysosomal activity, and sphingolipid metabolism in murine atherosclerosis. Arterioscler Thromb Vasc Biol. 2021;41:651–67. https://doi.org/10.1161/atvbaha.120.315669

Article  CAS  PubMed  Google Scholar 

Reimers GJ, Jackson CL, Rickards J, Chan PY, Cohn JS, Rye KA, et al. Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I. Cardiovasc Res. 2011;91:37–44. https://doi.org/10.1093/cvr/cvr057

Article  CAS  PubMed  Google Scholar 

Yuan W, Shao Y, Zhao D, Zhang B. Correlation analysis of lipid accumulation index, triglyceride-glucose index and H-type hypertension and coronary artery disease. PeerJ. 2023;11:e16069 https://doi.org/10.7717/peerj.16069

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baszczuk A, Musialik K, Kopczyński J, Thielemann A, Kopczyński Z, Kęsy L, et al. Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension. Adv Med Sci. 2014;59:68–73. https://doi.org/10.1016/j.advms.2013.08.001

Article  PubMed  Google Scholar 

Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA. 1994;91:6369–73. https://doi.org/10.1073/pnas.91.14.6369

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bortolotto LA, Safar ME, Billaud E, Lacroix C, Asmar R, London GM, et al. Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension (Dallas, Tex: 1979). 1999;34:837–42. https://doi.org/10.1161/01.hyp.34.4.837

Article  CAS  PubMed